Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

NCT: NCT02071134 · RECRUITING

NCT IDNCT02071134
StatusRECRUITING
Start Date2014-03-04
Completion2038-12

Brief Summary

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated. Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.

Frequently Asked Questions

What is Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry?

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry is a clinical trial registered under NCT02071134. Current status: RECRUITING.

What is the status of NCT02071134?

The current status of NCT02071134 (Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry) is: RECRUITING.

When did Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry start?

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry started on 2014-03-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑